Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills

Eli Lilly Eli Lilly LLY $ 1,223.04 $39.88 3.37% 12% IBD Stock Analysis Stock rebounding from 50-day, above 21-day/10-day lines Buy point is 1249.45 Investors can use 1,200 as early entry but LLY has been volatile IBD Composite Rating 98/99 Industry Group Ranking 58/197 Emerging Pattern Flat Base Flat Base One of three positive chart patterns to look for when…